Dr. Colby Shane Brownlee, DO

Dr. Brownlee practices at Surgical Center of Midland in Midland, Texas.

Dr. Brownlee's NPI, 1114289329, was assigned on June 13, 2012. Dr. Brownlee graduated from Texas College of Osteopathic Medicine in 2012. Dr. Brownlee holds Texas license Q9302.

Dr. Brownlee's primary practice is Surgical Center of Midland, at 2706 West Cuthbert, Building A, Midland, TX 79701. The practice phone is (432) 694-6517.

Dr. Brownlee's primary practice is Surgical Center of Midland in Midland, Texas. Dmand AI also links Dr. Brownlee to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brownlee practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Brownlee's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Brownlee is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Brownlee is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Brownlee treats.

CMS data shows 4,175 Medicare services from Dr. Brownlee across 16 procedure codes in 2024, for 1,067 Medicare patients. Medicare paid $422,842 for them.

CMS counts 1,067 Medicare patients who saw Dr. Brownlee in 2024. The largest group is 65 to 74, with 550 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brownlee's median patient age at 73, with 57% women.

In 2024, Dr. Brownlee wrote 5,596 Medicare Part D claims for 971 patients. 58% of them were for generic drugs. CMS names the drug for 5,493 of them, across 26 drugs with 11 or more claims each, at $272,515 in total drug cost. In 2023, CMS named 4,893 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Brownlee for performance year 2024, reported as part of a group. Dr. Brownlee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 816 procedures of cataract surgery by Dr. Brownlee, more than 98% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Brownlee in 2012. Dr. Brownlee's most frequent co-author is Brett H. Mueller, DO, PhD.

CMS Open Payments shows 55 general payments to Dr. Brownlee from 19 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Bausch & Lomb Americas Inc. paid the most, $532.

Dr. Brownlee graduated from Texas College of Osteopathic Medicine in 2012.

Dr. Brownlee is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.